Comments

Bio-Path Hldgs Stock Price, Quotes and Forecasts

Q: What sector and industry does Bio-Path Hldgs (BPTH) operate in?

Bio-Path Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the OTCQB.

BPTHOTCQB

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Bio-Path Hldgs (BPTH) Forecast

News Earnings Bio-Path Hldgs (BPTH) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Bio-Path Hldgs Stock Price, Quotes and Forecasts | OTC:BPTH | Benzinga

Explore Bio-Path Hldgs stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for BPTH.

Open	-
Close	-
Volume / Avg.	0 / -
Day Range	- - -
52 Wk Range	- - -
Market Cap	-
P/E Ratio	-
Dividend Yield	-
Exchange	OTC
RSI	0
Short Interest	-
Days to Cover	1

Recent News

US Stocks Mixed; NY State Business Activity Rises In February

Avi Kapoor

Nasdaq Jumps 100 Points, US Initial Jobless Claims Decline

Avi Kapoor

Bio-Path Holdings Shares Were On The Rise: What's Going On?

Bio-Path Holdings, Inc. (NASDAQ: BPTH) shares are surging Thursday following the company's announcement of encouraging preclinical results for BP1001-A, a potential treatment for obesity and Type 2 diabetes. Here's what you need to know.

Vaishali Prayag

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	-
Close	-
Volume / Avg.	0 / -
Day Range	- - -
52 Wk Range	- - -
Market Cap	-
P/E Ratio	-
Dividend Yield	-
Exchange	OTC
RSI	0
Short Interest	-
Days to Cover	1

About Bio-Path Holdings Inc

Sector

Health Care

Industry

Biotechnology

Bio-Path Holdings Inc is a clinical and preclinical stage oncology-focused RNAi nanoparticle drug de...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Bio-Path Hldgs (BPTH) stock?

You can purchase shares of Bio-Path Hldgs (OTCQB:BPTH) through any online brokerage.

View our list of the best stock brokerages

Who are Bio-Path Hldgs (BPTH) competitors?

There are no as such competitors for Bio-Path Hldgs.

What is the forecast, or price target, for Bio-Path Hldgs (BPTH) stock?

Bio-Path Hldgs has a consensus price target of $23.00.

What is the current price for Bio-Path Hldgs (BPTH)?

The stock price for Bio-Path Hldgs (OTCQB: BPTH) is $0.16145 last updated February 26, 2025 at 8:00 AM EST.

Does Bio-Path Hldgs (BPTH) pay a dividend?

There are no upcoming dividends for Bio-Path Hldgs.

When is Bio-Path Hldgs (OTCQB:BPTH) reporting earnings?

Bio-Path Hldgs’s Q1 earnings are confirmed for Wednesday, May 14, 2025.

Is Bio-Path Hldgs (BPTH) going to split?

There is no upcoming split for Bio-Path Hldgs.

What sector and industry does Bio-Path Hldgs (BPTH) operate in?

Bio-Path Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the OTCQB.